Andersons pediatric cardiology 1577

AnnotatedReferences
ShinYS.Glycogenstoragedisease:clinical,
biochemicalandmolecularheterogeneity.Semin
PediatrNeurol.2006;115–120.
Anexcellentdescriptionoftheglycogenstorage
diseases,withupdatesongenetics,biochemistry,
andclinicalfeatures.
ScottHS,BungeS,GalA,etal.Molecular
geneticsofmucopolysaccharidosistypeI:
diagnostic,clinical,andbiologicalimplications.
HumMutat.1995;6(4):288–302.
Thispaperreviewsthegeneticmutationsleadingto
MPSIandmakesgenotype/phenotype
correlationstohelpexplaintheclinical
heterogeneityofthemucopolysaccharidestorage
disorders.
DangelJH.Cardiovascularchangesinchildren
withmucopolysaccharidestoragediseasesand
relateddisorders:clinicalandechocardiographic
findingsin64patients.EurJPediatr.
1998;157:534–538.
Thelargestdescriptiveseriesavailableforthe
cardiacfindingsinpatientswith
mucopolysaccharidestoragedisorders.
MichalskiJC,KleinA.Glycoproteinlysosomal


storagedisorders:alphaandbetamannosidosis,
fucosidosis,andalpha-Nacetylgalactosaminidasedeficiency.Biochim
BiophysActa.1999;1455(2–3):69–84.
Thisisanexcellentreviewofthebiochemistry,

geneticsandclinicalfeaturesofthe
glycoproteinoses.
EngCM,GermainDP,BanikazemiM,etal.Fabry
disease:guidelinesfortheevaluationand
managementofmulti-organsysteminvolvement.
GenetMed.2006;8(9):539–548.
Thisisacomprehensivereviewofthemanagement
issuesforpatientswithFabry'sdiseasewhich
alsotouchesonthegeneticandbiochemical
aspectsofthedisease.
GuertlB,NoehammerC,HoeflerG.Metabolic
cardiomyopathies.IntJExpPathol.
2000;81(6):349–372.
Thisisanexcellentreviewofmyocardial
metabolismwhichexploresthevarious
metaboliccardiomyopathiesinasequential
fashion.Italsoprovidesinformationonother
cardiomyopathiesduetostoragedisorders,
toxins,anddefectsofenergymetabolism.
Marin-GarciaJ,GoldenthalMJ,FilianoJJ.
Cardiomyopathyassociatedwithneurologic
disordersandmitochondrialphenotype.JChild


Neurol.2002;17(10):759–765.
Thisreviewofcasesprovidesagooddescriptionof
thebreadthofmitochondrialdisordersaffecting
cardiacfunction.
SpencerCT,BryantRM,DayJ,etal.Cardiacand
clinicalphenotypeinBarthsyndrome.

Pediatrics.2006;118(2):e337–e346.
Adescriptivereviewofalargeseriesofpatients
withBarthsyndrome,coveringgenetic,clinical
andlaboratoryfindingswithafocuson
cardiovascularinvolvement.
DePaepeA,DevereuxRB,DietzHC,Hennekam
RC,PyeritzRE.Reviseddiagnosticcriteriafor
theMarfansyndrome.AmJMedGenet.
1996;62(4):417–426.
Theclassicmanuscriptdefiningtheconsensus
nosologyusedtodiagnoseMarfansyndrome,
alongwithusefulindexedtablesfor
measurementofthesinusesofValsalva.
RamirezF,DietzHC.Marfansyndrome:from
molecularpathogenesistoclinicaltreatment.
CurrOpinGenetDev.2007;17(3):252–258.
Thispaperisacomprehensivereviewdescribing
themostrecentadvancesintheunderstandingof
themolecularpathogenesisoftheclinical
featuresofMarfansyndrome.
WagnerKR,LechtzinN,JudgeDP.Current